Article Details


Bispecific Antibodies (bsAbs): Promising Immunotherapeutic Agents for Cancer Therapy

[ Vol. 24 , Issue. 5 ]

Author(s):

Deasmond O. Acheampong, Christian K. Adokoh, Paulina Ampomah, Daniel S. Agyirifor, Isaac Dadzie, Francis A. Ackah and Ernest A. Asiamah   Pages 456 - 465 ( 10 )

Abstract:


Antibodies have become the preferred therapeutic treatment option for cancers. Antibody therapy is associated with low toxic profile and specific in its activity, unlike chemotherapy and radiotherapy. Types of tumor are known to express multiple receptors that cross-talk to activate perpetual growth, proliferation and metastasis, and inhibit apoptosis in such tumors. Bispecific antibodies (BsAbs) are therefore the preferred agent for the treatment of such cancers due to its unique characteristics. This review discusses up to date therapeutic potentials of BsAbs.

Keywords:

Antibody, bispecific antibody (BsAb), immunotherapeutic agent, cancer therapy, diabody, antitumor.

Affiliation:

Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Department of Forensic Sciences, School of Biological Sciences, University of Cape Coast, Cape Coast, Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Department of Molecular Biology and Biotechnology, School of Biological Sciences, University of Cape Coast, Cape Coast, Department of Medical Laboratory Technology, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Department of Biomedical Sciences, School of Allied Health Sciences, University of Cape Coast, Cape Coast, Department of Forensic Sciences, School of Biological Sciences, University of Cape Coast, Cape Coast

Graphical Abstract:



Read Full-Text article